Drug Sponsors

Perrigo to acquire OTC portfolio from GlaxoSmithKline

Wednesday, June 3, 2015 12:39 PM

Perrigo has entered into an agreement to acquire a portfolio of established over-the-counter (OTC) brands from GlaxoSmithKline Consumer Healthcare, in connection with GSK's commitments to the E.C. and other regulators to divest these businesses in the context of the formation of a consumer health joint venture between GSK and Novartis International. Perrigo will acquire the following assets in an all-cash transaction:

More... »


Baxter, Mayo and Velocity launch Vitesse Biologics

Wednesday, June 3, 2015 12:35 PM

Baxter Ventures, the Mayo Clinic and Velocity Pharmaceutical Development (VPD) have formed Vitesse Biologics. Vitesse is a unique collaboration model initiated by Baxter Ventures to focus on the development of antibody and protein-based therapeutics in immunology, hematology and oncology.

More... »


Active Biotech adjusts organization, cuts 47 jobs

Wednesday, June 3, 2015 12:29 PM

Active Biotech, a biotechnology company based in Sweden, plans to reduce 47 positions and engage in significant down-sizing of operations due to recent negative trial results.

More... »

Juno Therapeutics acquires X-BODY

Wednesday, June 3, 2015 12:25 PM

Juno Therapeutics, a Seattle-based biopharmaceutical company focused on re-engaging the body's immune system to treat cancer, has acquired X-BODY, a privately held biotechnology company with nine employees based in Waltham, Mass. The acquisition furthers Juno's strategy of investing in technologies that augment the company's capabilities to create best-in-class engineered T cells against a broad array of cancer targets. The acquisition brings in-house to Juno an innovative discovery platform that interrogates the human antibody repertoire, rapidly selecting fully human antibodies with desired characteristics, even against difficult targets.

More... »

Johnson & Johnson to acquire Cardinal Health’s Cordis business

Monday, June 1, 2015 10:36 AM

Johnson & Johnson has accepted the March 1 binding offer from Cardinal Health to acquire its Cordis business for approximately $2 billion. The offer was accepted after consultations with relevant works councils and trade unions. The company expects the transaction to close toward the end of 2015, subject to regulatory clearances and other customary closing conditions.

More... »

Pfizer launches $3M grants program to further breast cancer research

Friday, May 29, 2015 02:37 PM

Pfizer has launched a competitive, peer-reviewed grants program to support clinical research projects investigating Ibrance (palbociclib) in advanced breast cancer.

More... »

Gilead opens innovative new laboratory, announces additional $100M investment

Thursday, May 28, 2015 03:13 PM

Gilead Alberta, a wholly-owned subsidiary of Gilead Sciences, has opened the first of two new laboratory buildings at its Edmonton, Canada campus, and announced an additional $100 million investment to further expand and upgrade the site as the biopharmaceutical company broadens its pipeline of treatments in areas of unmet medical need.

More... »

Allergen Research changes name to Aimmune Therapeutics

Thursday, May 28, 2015 03:12 PM

Allergen Research, a Brisbane, Calif.-based privately held biopharmaceutical company developing desensitization treatments for food allergies, has changed its name to Aimmune Therapeutics.

More... »

Bayer to restructure

Wednesday, May 27, 2015 12:23 PM

The Bayer Group has released a financial update for 2014. The company had strengthened its life science businesses HealthCare and CropScience through acquisitions and decided to demerge the MaterialScience business. Dr. Marijn Dekkers, management board chairman, also listed four strategic priorities for Bayer’s successful further development.

More... »

AVEO Oncology relocates corporate headquarters in Massachusetts

Wednesday, May 27, 2015 12:22 PM

AVEO Oncology, a biopharmaceutical company developing targeted therapies through biomarker-driven insights, has relocated its corporate headquarters to Cambridge, Mass.

More... »

CWWeekly

July 6

FDA sued by advocacy groups seeking hepatitis C trials data

Google to test health-tracking wristband to collect clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs